Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy

被引:34
|
作者
Lionetti, Vincenzo [1 ,2 ]
Matteucci, Marco [1 ]
Ribezzo, Marco [3 ]
Di Silvestre, Dario [4 ]
Brambilla, Francesca [4 ]
Agostini, Silvia [1 ]
Mauri, Pierluigi [4 ]
Padeletti, Luigi [5 ]
Pingitore, Alessandro [6 ]
Delsedime, Luisa [7 ]
Rinaldi, Mauro [3 ]
Recchia, Fabio A. [1 ,8 ]
Pucci, Angela [9 ]
机构
[1] Scuola Super Sant Anna, Inst Life Sci, Lab Med Sci, I-56124 Pisa, Italy
[2] Fdn CNR Reg Toscana G Monasterio, Pisa, Italy
[3] San Giovanni Battista Univ Hosp, Dept Cardiac Surg, Turin, Italy
[4] CNR, Inst Biomed Technol ITB, I-20133 Milan, Italy
[5] Univ Florence, Dept Med & Surg Crit Care, Florence, Italy
[6] CNR, Inst Clin Physiol, I-56100 Pisa, Italy
[7] S Giovanni Battista Univ Hosp, Dept Histopathol, Turin, Italy
[8] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19122 USA
[9] Univ Hosp Pisa, Dept Pathol, Pisa, Italy
关键词
pathologic features; hibernating myocardium; chronic heart failure; idiopathic dilated cardiomyopathy; ischaemic microenvironment; nestin; POSITRON-EMISSION-TOMOGRAPHY; HEART-FAILURE; CONTRACTILE DYSFUNCTION; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; CORONARY FLOW; RESERVE; ISCHEMIA; DEGRADATION; MECHANISMS;
D O I
10.1111/jcmm.12198
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Myocardial hibernation (MH) is a well-known feature of human ischaemic cardiomyopathy (ICM), whereas its presence in human idiopathic dilated cardiomyopathy (DCM) is still controversial. We investigated the histological and molecular features of MH in left ventricle (LV) regions of failing DCM or ICM hearts. We examined failing hearts from DCM (n=11; 41.9 +/- 5.45years; left ventricle-ejection fraction (LV-EF), 18 +/- 3.16%) and ICM patients (n=12; 58.08 +/- 1.7years; LVEF, 21.5 +/- 6.08%) undergoing cardiac transplantation, and normal donor hearts (N, n=8). LV inter-ventricular septum (IVS) and antero-lateral free wall (FW) were transmurally (i.e. sub-epicardial, mesocardial and sub-endocardial layers) analysed. LV glycogen content was shown to be increased in both DCM and ICM as compared with N hearts (P<0.001), with a U-shaped transmural distribution (lower values in mesocardium). Capillary density was homogenously reduced in both DCM and ICM as compared with N (P<0.05 versus N), with a lower decrease independent of the extent of fibrosis in sub-endocardial and sub-epicardial layers of DCM as compared with ICM. HIF1- and nestin, recognized ischaemic molecular hallmarks, were similarly expressed in DCM-LV and ICM-LV myocardium. The proteomic profile was overlapping by similar to 50% in DCM and ICM groups. Morphological and molecular features of MH were detected in end-stage ICM as well as in end-stage DCM LV, despite epicardial coronary artery patency and lower fibrosis in DCM hearts. Unravelling the presence of MH in the absence of coronary stenosis may be helpful to design a novel approach in the clinical management of DCM.
引用
收藏
页码:396 / 414
页数:19
相关论文
共 50 条
  • [1] Study an microbial persistence in end-stage idiopathic dilated cardiomyopathy
    de Leeuw, N
    Melchers, WJG
    Balk, AHMM
    de Jonge, N
    Galama, JMD
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (03) : 522 - 525
  • [2] Myocardial gene expression of osteopontin is higher in idiopathic than ischemic end-stage dilated cardiomyopathy
    Cabiati, M.
    Svezia, B.
    Botta, L.
    Caselli, C.
    Pucci, A.
    Lionetti, V.
    Del Ry, S.
    EUROPEAN HEART JOURNAL, 2015, 36 : 385 - 386
  • [3] Regional flow-metabolism mismatch mimicking myocardial hibernation in idiopathic dilated cardiomyopathy
    Neglia, D
    Pratali, L
    Iozzo, P
    Marini, C
    Menichetti, L
    Salvadori, P
    Gorini, I
    Carabba, S
    Sambuceti, G
    L'Abbate, A
    CIRCULATION, 2003, 108 (17) : 662 - 662
  • [4] Coronary atherosclerosis in end-stage idiopathic dilated cardiomyopathy:: an innocent bystander?
    Repetto, A
    Dal Bello, B
    Pasotti, M
    Agozzino, M
    Viganò, M
    Klersy, C
    Tavazzi, L
    Arbustini, E
    EUROPEAN HEART JOURNAL, 2005, 26 (15) : 1519 - 1527
  • [5] TREATMENT OF END-STAGE DILATED CARDIOMYOPATHY
    OCONNELL, JB
    MOORE, CK
    WATERER, HC
    BRITISH HEART JOURNAL, 1994, 72 (06): : S52 - S56
  • [6] Evaluation of appropriate pacing with myocardial perfusion and cardiac function as a treatment of end-stage idiopathic dilated cardiomyopathy
    Watanabe, T
    Okazaki, O
    Izumo, K
    Akutsu, Y
    Katagiri, T
    Harumi, K
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1999, 22 (12): : 1844 - 1845
  • [7] No evidence for persistent enterovirus infection in cattle with end-stage idiopathic dilated cardiomyopathy
    Nart, P
    Nicolson, L
    Morrison, M
    RESEARCH IN VETERINARY SCIENCE, 2003, 75 (03) : 241 - 244
  • [8] No evidence for persistent enterovirus infection in patients with end-stage idiopathic dilated cardiomyopathy
    de Leeuw, N
    Melchers, WJG
    Balk, AHMM
    de Jonge, N
    Galama, JMD
    JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01): : 256 - 259
  • [9] Results of partial left ventriculectomy in patients with end-stage idiopathic dilated cardiomyopathy
    Dowling, RD
    Koenig, S
    Laureano, MA
    Cerrito, P
    Gray, LA
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1998, 17 (12): : 1208 - 1212
  • [10] NICARDIPINE TESTING IN END-STAGE DILATED IDIOPATHIC CARDIOMYOPATHY WITH PULMONARY-HYPERTENSION
    TAMBURINO, C
    RUSSO, G
    DIPAOLA, R
    GIUFFRIDA, G
    ADVANCES IN THERAPY, 1992, 9 (01) : 46 - 51